Krsnaa Diagnostics Ltd
NSE:KRSNAA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Krsnaa Diagnostics Ltd
Operating Income
Krsnaa Diagnostics Ltd
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Krsnaa Diagnostics Ltd
NSE:KRSNAA
|
Operating Income
₹1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Dr Agarwal's Eye Hospital Ltd
BSE:526783
|
Operating Income
₹994.2m
|
CAGR 3-Years
29%
|
CAGR 5-Years
83%
|
CAGR 10-Years
45%
|
|
|
Thyrocare Technologies Ltd
NSE:THYROCARE
|
Operating Income
₹1.9B
|
CAGR 3-Years
25%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
|
Dr. Lal PathLabs Ltd
NSE:LALPATHLAB
|
Operating Income
₹6.1B
|
CAGR 3-Years
21%
|
CAGR 5-Years
16%
|
CAGR 10-Years
14%
|
|
|
Vijaya Diagnostic Centre Ltd
NSE:VIJAYA
|
Operating Income
₹2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Metropolis Healthcare Ltd
NSE:METROPOLIS
|
Operating Income
₹2.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
Krsnaa Diagnostics Ltd
Glance View
Krsnaa Diagnostics Ltd. engages in the provision of diagnostics services. The company is headquartered in Pune, Maharashtra. The company went IPO on 2021-08-16. The firm is focused on providing radiology and pathology services for -radiation (X-rays), computed tomography (CT) scan, magnetic resonance imaging (MRI), mammography, tele- reporting services, and all types of blood and urine investigation. The firm operates within India and has diagnostic centers all over India. The Company' studies in CT Scan include Peripheral Angio, Urography, Coronary Angio, Cisternography, CT Brain, CT Abdomen Triple Phase, CT HRCT Temporal Bone, CT Dentascan, CT Brain Angio, CT Perfusion, CT Renal Angio, CT Aortography and CT Pulmonary Angio. The Company’s services in color doppler include upper limb arterial doppler, upper limb venous doppler, lower limb arterial doppler, lower limb venous doppler, carotid doppler, hepatosplenic doppler, obstetric doppler and scrotal doppler.
See Also
What is Krsnaa Diagnostics Ltd's Operating Income?
Operating Income
1B
INR
Based on the financial report for Mar 31, 2025, Krsnaa Diagnostics Ltd's Operating Income amounts to 1B INR.
What is Krsnaa Diagnostics Ltd's Operating Income growth rate?
Operating Income CAGR 3Y
4%
Over the last year, the Operating Income growth was 46%. The average annual Operating Income growth rates for Krsnaa Diagnostics Ltd have been 4% over the past three years .
